arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

AETHLON MEDICAL INC

AEMD
$6.82 ▲ +0.16 (+2.33%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
64 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

AETHLON MEDICAL INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.6M
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC -24.0%
FCF / Share $-4.95
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$574.25K
↑ +4278.2%
Net Income Profit after all expenses
$-1.55M
↑ +12.1%
Operating Margin Operating profit as % of sales
-431.5%
↓ -10.3%
FCF / Share Free cash flow per share
$-4.95
↓ -499.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
4
Cash Quality
59

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 64 quarters